No Data
No Data
AU Evening Wrap: Australian Stocks End Down 0.5%, Energy Sector Leads Decline
Australian stocks end down 0.5%, energy sector leads decline.
Here Are Big Pharma's Leading Blockbuster Makers
Executive Reshuffles: Otis Worldwide, HSBC and Rockwell Automation in Focus
Wolfe Research Reinstates Peer Perform on Shell
Wolfe Research analyst Doug Leggate reinstates Shell (NYSE:SHEL) with a Peer Perform.
Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Drugs
Swiss pharma giant Novartis AG (NYSE:NVS) reported a second-quarter adjusted EPS of $1.97, up 21% year over year (+17% on constant currency), beating the consensus of $1.89.The company's sales
Novartis Shares Are Trading Lower. The Company Reported Q2 Financial Results.
Novartis Shares Are Trading Lower. The Company Reported Q2 Financial Results.